Aspen Pharmacare Shares Outstanding 2017-2023 | APNHY
Aspen Pharmacare shares outstanding from 2017 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Aspen Pharmacare Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
444 |
| 2022 |
453 |
| 2021 |
457 |
| 2020 |
457 |
| 2019 |
457 |
| 2018 |
457 |
| 2017 |
456 |
| 2016 |
457 |
| 2015 |
|
Aspen Pharmacare Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2016-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$4.985B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
